Advertisement
Singapore markets close in 52 minutes

  • Straits Times Index

    3,300.58
    -2.61 (-0.08%)
     

  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     

  • Hang Seng

    18,473.07
    -105.23 (-0.57%)
     

  • FTSE 100

    8,282.61
    +69.12 (+0.84%)
     

  • Bitcoin USD

    63,714.19
    -894.54 (-1.38%)
     

  • CMC Crypto 200

    1,370.04
    +4.92 (+0.36%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • Dow

    38,852.27
    +176.59 (+0.46%)
     

  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     

  • Gold

    2,327.30
    -3.90 (-0.17%)
     

  • Crude Oil

    78.37
    -0.11 (-0.14%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • FTSE Bursa Malaysia

    1,606.91
    +9.52 (+0.60%)
     

  • Jakarta Composite Index

    7,141.72
    +5.83 (+0.08%)
     

  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

Why OPKO Health Shares Were Up 10% Today

Todd Campbell, The Motley Fool
·2-min read
Why OPKO Health Shares Were Up 10% Today

After announcing it has launched a COVID-19 screening program to help employers make return-to-work decisions for employees, OPKO Health (NASDAQ: OPK) saw its shares close the day up more than 10% on Thursday. OPKO Health's BioReference Labs has been assisting healthcare providers with COVID-19 testing services since mid-March. On Monday, management expanded its COVID-19 product platform with the launch of an antibody test that can determine if someone has been exposed to the virus, and on Wednesday, the healthcare company unveiled services designed to inform business decisions relating to employees.

Continue reading